Lost circulation composition for fracture sealing
US-2015376491-A1 · Dec 31, 2015 · US
US2017036959A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017036959-A1 |
| Application number | US-201615332491-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 24, 2016 |
| Priority date | Mar 9, 2012 |
| Publication date | Feb 9, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are lost circulation treatment fluids and methods of sealing lost circulation zones. Embodiments include a lost circulation treatment fluid comprising pumice, hydrated lime, a set retarder, and water.
Opening claim text (preview).
What is claimed is: 1 . A lost circulation treatment fluid comprising: pumice, hydrated lime, a set retarder, and water. 2 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model. 3 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid further comprises aluminum sulfate. 4 . The lost circulation treatment fluid of claim 1 wherein the set retarder comprises at least one retarder selected from the group consisting of a phosphonic acid, a phosphonic acid derivative, a lignosulfonate, a salt, an organic acid, a carboxymethylated hydroxyethylated cellulose, a synthetic co- or ter-polymer comprising sulfonate and carboxylic acid groups, a borate compound, and any mixture thereof. 5 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid further comprises a dispersant selected from the group consisting of a sulfonated-formaldehyde-based dispersant, a polycarboxylated ether dispersant, and any combination thereof. 6 . The lost circulation treatment fluid of claim 1 wherein the set retarder comprises a phosphonic acid derivative, and wherein the set-delayed cement composition further comprises a polycarboxylated ether dispersant. 7 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid further comprises a cement set activator, and wherein the cement set activator comprises at least one cement set activator selected from the group consisting of calcium chloride, triethanolamine, sodium silicate, zinc formate, calcium acetate, sodium hydroxide, sodium sulfate, nanosilica, sodium hexametaphosphate, and any combinations thereof. 8 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid has a density in the range of from about 8 lb/gal to about 17 lb/gal. 9 . A lost circulation treatment fluid comprising: pumice, hydrated lime, a set retarder, and water; wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model, wherein the lost circulation treatment fluid has a static gel strength of at least about 100 lb/100 ft 2 at a temperature of about 50° F. to about 200° F. 10 . The lost circulation treatment fluid of claim 9 wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model. 11 . The lost circulation treatment fluid of claim 9 further comprising aluminum sulfate. 12 . The lost circulation treatment fluid of claim 9 wherein the set retarder comprises at least one retarder selected from the group consisting of a phosphonic acid, a phosphonic acid derivative, a lignosulfonate, a salt, an organic acid, a carboxymethylated hydroxyethylated cellulose, a synthetic co- or ter-polymer comprising sulfonate and carboxylic acid groups, a borate compound, and any mixture thereof. 13 . The lost circulation treatment fluid of claim 9 further comprising a dispersant selected from the group consisting of a sulfonated-formaldehyde-based dispersant, a polycarboxylated ether dispersant, and any combination thereof. 14 . The lost circulation treatment fluid of claim 9 wherein the set retarder comprises a phosphonic acid derivative, and wherein the set-delayed cement composition further comprises a polycarboxylated ether dispersant. 15 . The lost circulation treatment fluid of claim 9 further comprising a cement set activator, and wherein the cement set activator comprises at least one cement set activator selected from the group consisting of calcium chloride, triethanolamine, sodium silicate, zinc formate, calcium acetate, sodium hydroxide, sodium sulfate, nanosilica, sodium hexametaphosphate, and any combinations thereof. 16 . The lost circulation treatment fluid of claim 9 wherein the lost circulation treatment fluid is a set-delayed cement composition capable of remaining in a pumpable fluid state for about 1 day or longer at a temperature of about 100° F. 17 . The lost circulation treatment fluid of claim 9 wherein the lost circulation treatment fluid has a static gel strength of at least about 500 lb/100 ft 2 at a temperature of about 50° F. to about 200° F. 18 . A lost circulation treatment system comprising: a lost circulation treatment fluid comprising: pumice, hydrated lime, a set retarder, and water, wherein the lost circulation treatment fluid is a set-delayed cement composition capable of remaining in a pumpable fluid state for about 1 day or longer at a temperature of about 100° F.; and a cement set activator. 19 . The lost circulation treatment system of claim 18 wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model. 20 . The lost circulation treatment system of claim 18 wherein the lost circulation treatment fluid has a static gel strength of at least about 100 lb/100 ft 2 at a temperature of about 50° F. to about 200° F.
containing additives for specific purposes · CPC title
containing mixtures of the silica-lime type · CPC title
Set retarders · CPC title
Methods or devices for cementing, for plugging holes, crevices or the like · CPC title
Retarder inhibited mortars activated by the addition of accelerators or retarder-neutralising agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.